Literature DB >> 14746618

Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study.

I Zalaudek1, G Argenziano, G Ferrara, H P Soyer, R Corona, F Sera, L Cerroni, A Carbone, A Chiominto, L Cicale, G De Rosa, A Ferrari, R Hofmann-Wellenhof, J Malvehy, K Peris, M A Pizzichetta, S Puig, M Scalvenzi, S Staibano, V Ruocco.   

Abstract

BACKGROUND: Benign melanocytic skin lesions may be difficult to differentiate from melanoma both clinically and dermoscopically. One of the most confounding dermoscopic features, commonly seen in melanoma but in our experience also in melanocytic naevi, is represented by the so-called blue-white structures (BWS).
OBJECTIVES: To evaluate diagnostic significance and histopathological correlates of BWS seen by dermoscopy in a series of clinically equivocal melanocytic skin lesions that were excised.
METHODS: Patients were recruited from six specialized pigmented lesion clinics in Austria, Italy and Spain over a period of 9 months. All consecutive patients showing one or more melanocytic lesions with BWS, but not classified as melanoma dermoscopically, were included. Each lesion was photographed clinically and dermoscopically. All images were reviewed by one of us and the degree, type and location of BWS evaluated for each lesion. A panel of four experienced dermatopathologists independently reviewed all specimens for diagnosis and one of them evaluated presence and degree of melanosis and/or fibrosis. The main outcome measures were the percentage and histopathological correlates of lesions with different degree, type and location of BWS.
RESULTS: All included lesions with BWS (n = 158) showed partial or focal regression histopathologically. One hundred and thirty-five (85.4%) lesions were diagnosed as melanocytic naevi (complete histopathological interobserver agreement), whereas 23 (14.6%) were defined as equivocal because at least one of four pathologists diagnosed the given lesion as melanoma. Only one lesion was diagnosed as melanoma by all four pathologists. The majority of naevi exhibited blue areas (84.4%) with a central distribution (57%) and involving < 50% of the lesion surface (89.6%). By contrast, 78.3% of equivocal lesions revealed a combination of white and blue areas with an irregular distribution (60.9%) and involving > 50% of the lesion surface (47.8%).
CONCLUSIONS: Using degree and type of BWS, an algorithm was constructed that can be applied for the management of lesions exhibiting dermoscopic features of regression.

Entities:  

Mesh:

Year:  2004        PMID: 14746618     DOI: 10.1111/j.1365-2133.2004.05657.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  18 in total

1.  [Early melanoma as opposed to a benign nevus, nevus-associated melanoma, or halo nevus with regression?].

Authors:  P Y Basak; R Hofmann-Wellenhof
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

2.  Concentric decile segmentation of white and hypopigmented areas in dermoscopy images of skin lesions allows discrimination of malignant melanoma.

Authors:  Ankur Dalal; Randy H Moss; R Joe Stanley; William V Stoecker; Kapil Gupta; David A Calcara; Jin Xu; Bijaya Shrestha; Rhett Drugge; Joseph M Malters; Lindall A Perry
Journal:  Comput Med Imaging Graph       Date:  2010-11-12       Impact factor: 4.790

3.  Detection of granularity in dermoscopy images of malignant melanoma using color and texture features.

Authors:  William V Stoecker; Mark Wronkiewiecz; Raeed Chowdhury; R Joe Stanley; Jin Xu; Austin Bangert; Bijaya Shrestha; David A Calcara; Harold S Rabinovitz; Margaret Oliviero; Fatimah Ahmed; Lindall A Perry; Rhett Drugge
Journal:  Comput Med Imaging Graph       Date:  2010-10-30       Impact factor: 4.790

4.  Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ.

Authors:  Aimilios Lallas; Caterina Longo; Marco Manfredini; Elisa Benati; Graziella Babino; Chiara Chinazzo; Zoe Apalla; Chryssoula Papageorgiou; Elvira Moscarella; Athanassios Kyrgidis; Giuseppe Argenziano
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

Review 5.  Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma.

Authors:  Nika Filipović; Mirna Šitum; Marija Buljan
Journal:  Dermatol Pract Concept       Date:  2021-04-12

6.  Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.

Authors:  Yasutomo Mikoshiba; Akane Minagawa; Hiroshi Koga; Yoshiharu Yokokawa; Hisashi Uhara; Ryuhei Okuyama
Journal:  JAMA Dermatol       Date:  2019-05-01       Impact factor: 10.282

Review 7.  Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi.

Authors:  Iris Zalaudek; Giovanni Docimo; Giuseppe Argenziano
Journal:  Arch Dermatol       Date:  2009-07

8.  Grey-blue regression in melanoma in situ-evaluation on 111 cases.

Authors:  S Bassoli; S Borsari; C Ferrari; F Giusti; G Pellacani; G Ponti; S Seidenari
Journal:  J Skin Cancer       Date:  2011-03-23

9.  Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Lavinia Ferrante di Ruffano; Rubeta N Matin; David R Thomson; Kai Yuen Wong; Roger Benjamin Aldridge; Rachel Abbott; Monica Fawzy; Susan E Bayliss; Matthew J Grainge; Yemisi Takwoingi; Clare Davenport; Kathie Godfrey; Fiona M Walter; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-04

10.  Extensive regression in pigmented skin lesions: a dangerous confounding feature.

Authors:  Aimilios Lallas; Zoe Apalla; Elvira Moscarella; Iris Zalaudek; Thrasivoulos Tzellos; Ioanna Lefaki; Carlo Cota; Giuseppe Argenziano
Journal:  Dermatol Pract Concept       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.